Valuation : AcouSort AB

Market Cap 62.22M 6.5M 5.6M 5.27M 4.81M 9M 614M 9.02M 24.13M 315M 24.41M 23.88M 1.02B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 62.22M 6.5M 5.6M 5.27M 4.81M 9M 614M 9.02M 24.13M 315M 24.41M 23.88M 1.02B EV / Sales 2026 *
6.29x
EV / Sales 2027 * 4.2x
Free-Float
70.68%
Yield 2026 *
-
Yield 2027 * -
1 day-8.13%
1 week-3.29%
Current month-2.97%
1 month-19.23%
3 months-37.18%
6 months+29.52%
Current year+3.89%
1 week 2.69
Extreme 2.69
3.39
1 month 2.5
Extreme 2.5
3.63
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 2013-12-31
Director of Finance/CFO 65 2015-12-31
Director TitleAgeSince
Director/Board Member 64 2011-12-31
Chairman 65 2010-12-31
Director/Board Member - 2021-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-8.12%-3.29%-6.67%-85.30% 6.5M
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average -1.64%+0.15%+65.08%+87.97% 27.5B
Weighted average by Cap. -1.03%+0.11%+89.42%+127.92%

Financials

2026 *2027 *
Net sales 9.9M 1.03M 891K 838K 765K 1.43M 97.72M 1.44M 3.84M 50.13M 3.88M 3.8M 163M 14.8M 1.55M 1.33M 1.25M 1.14M 2.14M 146M 2.15M 5.74M 74.95M 5.81M 5.68M 243M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
26-09-04 SEK 2.940 -8.13% 79,683
26-09-03 SEK 3.200 +5.61% 25,645
26-09-02 SEK 3.030 +1.68% 13,052
26-09-01 SEK 2.980 -1.65% 13,808
26-08-31 SEK 3.030 -0.33% 40,539

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock